These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16546533)

  • 61. Renin Angiotensin Aldosterone System (RAAS): its biology and drug targets for treating diabetic nephropathy.
    Zain M; Awan FR
    Pak J Pharm Sci; 2014 Sep; 27(5):1379-91. PubMed ID: 25176370
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Back to the Future: Paving the Way for the Next Generation of Renal Therapeutics.
    Brenner L
    Semin Nephrol; 2016 Nov; 36(6):481-487. PubMed ID: 27987550
    [No Abstract]   [Full Text] [Related]  

  • 63. Will angiotensin II receptor antagonists be renoprotective in humans?
    Ichikawa I
    Kidney Int; 1996 Aug; 50(2):684-92. PubMed ID: 8840302
    [No Abstract]   [Full Text] [Related]  

  • 64. Are renin-angiotensin system inhibitors optimally prescribed?
    Hirsch S
    Kidney Int; 2007 Mar; 71(5):469. PubMed ID: 17315014
    [No Abstract]   [Full Text] [Related]  

  • 65. Diabetic nephropathy--where next?
    Phillips AO
    QJM; 2000 Oct; 93(10):643-6. PubMed ID: 11029473
    [No Abstract]   [Full Text] [Related]  

  • 66. ACE inhibitors and AT1 receptor antagonists: is two better than one?
    Noris M; Remuzzi G
    Kidney Int; 2002 Apr; 61(4):1545-7. PubMed ID: 11918763
    [No Abstract]   [Full Text] [Related]  

  • 67. Angiotensin converting enzyme inhibitors: the end of end-stage renal disease?
    Feig PU; Rutan GH
    Ann Intern Med; 1989 Sep; 111(6):451-3. PubMed ID: 2672924
    [No Abstract]   [Full Text] [Related]  

  • 68. Inhibition of renin secretion by angiotensin II receptor blockage?
    Krämer BK; Endemann D; Fischereder M; Wolf K
    Kidney Int; 2001 Oct; 60(4):1612-3. PubMed ID: 11576384
    [No Abstract]   [Full Text] [Related]  

  • 69. Renin-angiotensin system: Meta-analyses can misdirect decisions on treatment.
    Ruggenenti P; Remuzzi G
    Nat Rev Nephrol; 2013 Jun; 9(6):311-2. PubMed ID: 23629638
    [No Abstract]   [Full Text] [Related]  

  • 70. Non-diabetic nephropathies and ACE inhibition.
    Pruna A; El Esper N; Makdassi R; Oprisiu R; Fournie A
    Lancet; 1999 Nov; 354(9193):1905-6. PubMed ID: 10584749
    [No Abstract]   [Full Text] [Related]  

  • 71. Authors' reply to Laragh and Sealey.
    Messerli FH; Makani H; Bangalore S
    BMJ; 2013 Mar; 346():f1689. PubMed ID: 23512454
    [No Abstract]   [Full Text] [Related]  

  • 72. Authors' reply to Messerli and colleagues.
    Laragh JH; Sealey JE
    BMJ; 2013 Apr; 346():f2288. PubMed ID: 23592467
    [No Abstract]   [Full Text] [Related]  

  • 73. Evolving strategies for renoprotection: non-diabetic chronic renal disease.
    Taal MW; Brenner BM
    Curr Opin Nephrol Hypertens; 2001 Jul; 10(4):523-31. PubMed ID: 11458034
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The COOPERATE trial.
    Vogt L; Laverman GD; de Zeeuw D; Navis G
    Lancet; 2003 Mar; 361(9362):1055-6. PubMed ID: 12660079
    [No Abstract]   [Full Text] [Related]  

  • 75. Three feasible strategies to minimize kidney injury in 'incipient AKI'.
    Perazella MA; Coca SG
    Nat Rev Nephrol; 2013 Aug; 9(8):484-90. PubMed ID: 23649020
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical pathology and treatment of renin-angiotensin system 2. Chronic kidney disease and the renin-angiotensin system.
    Kimura G
    Intern Med; 2007; 46(16):1295-8. PubMed ID: 17704608
    [No Abstract]   [Full Text] [Related]  

  • 77. Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease.
    Berry C; Anderson N; Kirk AJ; Dominiczak AF; McMurray JJ
    Heart; 2001 Aug; 86(2):217-20. PubMed ID: 11454847
    [No Abstract]   [Full Text] [Related]  

  • 78. Angiotensin-converting enzyme inhibitors in nondiabetic renal disease.
    Colindres RE; Kshirsagar AV
    Ann Intern Med; 1998 Apr; 128(8):694-5. PubMed ID: 9537948
    [No Abstract]   [Full Text] [Related]  

  • 79. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose containing intravenous immunoglobulins. A case-control study.
    Onuigbo MA
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):320-2. PubMed ID: 22238243
    [No Abstract]   [Full Text] [Related]  

  • 80. Reply to the commentary by Onuigbo on the article "Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins. A case-control study".
    Moulis G; Sailler L; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):900-1. PubMed ID: 22696169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.